Last updated at 30 Jun 2025 06:30 AM
Director
DIN: 08144111
Subhakar Kailasani is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at PRONTGEN HEALTH REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08144111.Subhakar Kailasani has previously been associated with 1 company in roles such as Director.Subhakar Kailasani is currently involved in 2 different roles. Their most recent position is with NEURAL PHARMA LLP as a Designated Partner. The first company Subhakar Kailasani was appointed to was PRONTGEN HEALTH REMEDIES PRIVATE LIMITED. Subhakar Kailasani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Subhakar Kailasani is currently associated with 2 companies in various capacities such as Individual Promoter and Designated Partner. They serve as a Director at PRONTGEN HEALTH REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08144111.Subhakar Kailasani has previously been associated with 1 company in roles such as Director.Subhakar Kailasani is currently involved in 2 different roles. Their most recent position is with NEURAL PHARMA LLP as a Designated Partner. The first company Subhakar Kailasani was appointed to was PRONTGEN HEALTH REMEDIES PRIVATE LIMITED. Subhakar Kailasani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| PRONTGEN HEALTH REMEDIES PRIVATE LIMITED | Individual Promoter | 28-May-2018 |